EPIRUS BIOPHARMACEUTICALS
EPIRUS is focusing on the central development of a broad pipeline of biosimilar monoclonal antibodies and therapeutic proteins, optimized for use within the SCALEโข disposable manufacturing system, and designed to be deployed in an "In Market, For Market" โข manufacturing configuration.
EPIRUS BIOPHARMACEUTICALS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2000-03-28
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.epirusbiopharma.com
Total Employee:
11+
Status:
Active
Contact:
6176073437
Email Addresses:
[email protected]
Total Funding:
83.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Font Awesome Domain Not Resolving Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin Google Maps
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-09-09 | Bioceros | Bioceros acquired by Epirus Biopharmaceuticals | 14.1 M USD |
| 2014-07-15 | Zalicus | Zalicus acquired by Epirus Biopharmaceuticals | N/A |
Investors List
Livzon Mabpharm
Livzon Mabpharm investment in Series B - Epirus Biopharmaceuticals
TPG Biotech
TPG Biotech investment in Series B - Epirus Biopharmaceuticals
5AM Ventures
5AM Ventures investment in Series B - Epirus Biopharmaceuticals
Mousse Partners
Mousse Partners investment in Series B - Epirus Biopharmaceuticals
Greenwoods Investment
Greenwoods Investment investment in Series B - Epirus Biopharmaceuticals
Montreux Equity Partners
Montreux Equity Partners investment in Series B - Epirus Biopharmaceuticals
Gibralt Capital Corporation
Gibralt Capital Corporation investment in Series B - Epirus Biopharmaceuticals
Adage Capital Management
Adage Capital Management investment in Series B - Epirus Biopharmaceuticals
5AM Ventures
5AM Ventures investment in Venture Round - Epirus Biopharmaceuticals
Montreux Equity Partners
Montreux Equity Partners investment in Venture Round - Epirus Biopharmaceuticals
Official Site Inspections
http://www.epirusbiopharma.com
- Host name: 162.243.32.126
- IP address: 162.243.32.126
- Location: New York United States
- Latitude: 40.7308
- Longitude: -73.9975
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10011
More informations about "Epirus Biopharmaceuticals"
Epirus Biopharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 6176073437 EPIRUS is focusing on the central development of a broad pipeline of biosimilar monoclonal antibodies and โฆSee details»
Epirus Biopharmaceuticals - VentureRadar
"EPIRUS Biopharmaceuticals is a pure-play biosimilar company focused on the global development and commercialization of biosimilar monoclonal antibodies (mAbs).See details»
Epirus Biopharmaceuticals - Org Chart, Teams, Culture & Jobs
View Epirus Biopharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Epirus Biopharmaceuticals Inc (EPRSQ) Profile - The Globe and Mail
See the company profile for Epirus Biopharmaceuticals Inc (EPRSQ) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Epirus Biopharma - Company Profile - Tracxn
Feb 8, 2025 Epirus Biopharma - Develops biosimilar monoclonal antibodies and therapeutic proteins. Public Company. Raised a total funding of $44.5M over 4 rounds from 16 investors. โฆSee details»
EPIRUS Biopharmaceuticals - PitchBook
EPIRUS Biopharmaceuticals General Information Description. EPIRUS Biopharmaceuticals Inc is a global biopharmaceutical company focused on building biosimilar business targeting rare โฆSee details»
EPIRUS Biopharmaceuticals Inc. | Key People and Executives
EPIRUS Biopharmaceuticals Inc. board of directors, ownership, key people and executives. Detailed company description, list of companies executives for EPIRUS Biopharmaceuticals Inc.See details»
EPIRUS Biopharmaceuticals, Inc. - Drug pipelines, Patents
Epirusbiopharma.com. Public Company | 2000 | Massachusetts, United States | 50-100 | OTC: EPRSQ | epirusbiopharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. ... The โฆSee details»
Epirus Biopharmaceuticals - Products, Competitors, Financials ...
Epirusbiopharma.com. Overview & Products; Financials; People; Stage Merger | Merged. About Epirus Biopharmaceuticals. Epirus is building a global biosimilar enterprise to improve patient โฆSee details»
EPIRUS Biopharmaceuticals Overview | SignalHire Company Profile
EPIRUS Biopharmaceuticals (Nasdaq:EPRS) is a pure-play biosimilar company focused on the global development and commercialization of biosimilar monoclonal antibodies (mAbs). โฆSee details»
EPIRUS Biopharmaceuticals - Utrecht, Netherlands
Epirusbiopharma.com +3130 2537910. Share. Xing Linkedin Facebook X E-mail Loading... Bookmark. Bookmark list; Bookmark. EPIRUS Biopharmaceuticals. Yalelaan 46, Alexander โฆSee details»
EPIRUS Biopharmaceuticals - Business Information - ZoomInfo
EPIRUS Biopharmaceuticals contact info: Phone number: (617) 600-3497 Website: www.epirusbiopharma.com What does EPIRUS Biopharmaceuticals do? EPIRUS โฆSee details»
EPIRUS Biopharmaceuticals, Inc. | Insights
Other Names/Subsidiaries. Bioceros Holding B.V. CombinatoRx, Inc. EB Sub, Inc. Epirus Biopharmaceuticals Ltd. Epirus Biopharmaceuticals (Switzerland) GmbHSee details»
EPIRUS BIOPHARMCEUTICALS Revenue, Growth & Competitor โฆ
Epirusbiopharma.com (see exact revenue data) and has 10-100 employees. It is classified as operating in the Scientific Research & Development Services industry. Epirus โฆSee details»
Company EPIRUS Biopharmaceuticals, Inc. - MarketScreener.com
EPIRUS Biopharmaceuticals, Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | OTC Markets ...See details»
Epirus Biopharmaceuticals company information, funding
Epirus Biopharmaceuticals, expert insights on pharmaceuticals and health supplements to enhance mental and physical well-being. Here you'll find information about their funding, โฆSee details»
EPIRUS Biopharmaceuticals, Inc. Company Profile & Data: stocks, โฆ
Top 1-year algo backtest: +327.04% $10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.. Use AI to boost your investing & swing trading, now! Try โฆSee details»
EPIRUS Biopharmaceuticals, Inc. (EPIRUS Biopharmaceuticals, Inc.)
ไบ่งฃEPIRUS Biopharmaceuticals, Inc. (EPIRUS Biopharmaceuticals, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็22้กนไธดๅบ่ฏ้ช, 9็ฏๆฐ้ปๅ31็ฏๆ็ฎ๏ผ็พ็ ้ขๅ:ๅ ๅๆณไธไปฃ่ฐข็พ โฆSee details»
Boston-Based EPIRUS Biopharmaceuticals Reels In $36 Million
Apr 16, 2014 After an extensive review of potential merger candidates and their product pipelines, Zalicus identified Epirus as an organization with the potential to create significant โฆSee details»
Epirus grabs $36 mln Series B funds and merges with Zalicus
Apr 16, 2014 Epirus Biopharmaceuticals said Wednesday that it has secured $36 million in Series B funding. Livzon Mabpharm led the round with participation from other investors that โฆSee details»